Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics
Article in Current Pharmaceutical Design (January 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
ENTPD1 (CD39) and NT5E (CD73) expression in human Medulloblastoma: an in silico analysis
Preprint in Research Square (November 2023)
MBMethPred: a computational framework for the accurate classification of childhood medulloblastoma subgroups using data integration and AI-based approaches
Article in Frontiers in Genetics (September 2023)